TrialPanorama/TrialPanorama-database huggingface dataset:
Study 35987532 — Predictive Biomarker (PRD): COPE mRNA
Genes: COPE
Study 33769675 — Surrogate Endpoint (SUR): Blood pressure
Study 32438301 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33399254 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33399254 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34871153 — Surrogate Endpoint (SUR): Forced vital capacity
Study 32010972 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34265236 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33241650 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Tumor mutational burden
Study 34549539 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 35687793 — Predictive Biomarker (PRD): STS mRNA
Genes: STS; ARSC1
Study 33043347 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33043347 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 33043347 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study 33043347 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 35841716 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 35248549 — Safety Biomarker (SAF): APC
Genes: DP2; DP3; DP2.5; PPP1R46
Study 35248549 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 33973063 — Predictive Biomarker (PRD): RBFOX1 mRNA
Genes: RBFOX1; A2BP; A2BP1; FOX1; HRNBP1
Study 33973063 — Predictive Biomarker (PRD): SOX5 mRNA
Genes: SOX5
Study 33973063 — Predictive Biomarker (PRD): TCF7L2 mRNA
Genes: TCF7L2; TCF4
Study 33973063 — Predictive Biomarker (PRD): MAD1L1 mRNA
Genes: MAD1L1; MAD1; TXBP181
Study 33973063 — Predictive Biomarker (PRD): BMAL1 mRNA
Genes: BMAL1; ARNTL; BHLHE5; MOP3; PASD3
Study 33973063 — Predictive Biomarker (PRD): SOX6 mRNA
Genes: SOX6
Study 33017651 — Predictive Biomarker (PRD): TNFSF13 mRNA
Genes: TNFSF13; APRIL; TALL2; ZTNF2; UNQ383/PRO715
Study 33017651 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 36385314 — Predictive Biomarker (PRD): ADORA2A mRNA
Genes: ADORA2A; ADORA2
Study 36385314 — Predictive Biomarker (PRD): CYP1A2 mRNA
Genes: CYP1A2
Study 35271721 — Predictive Biomarker (PRD): CPD mRNA
Genes: CPD
Study 35271721 — Predictive Biomarker (PRD): FTCD mRNA
Genes: FTCD
Study 34448448 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 35643334 — Predictive Biomarker (PRD): AZIN2 mRNA
Genes: AZIN2; ADC; KIAA1945; ODCP
Study 34841235 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study 32379655 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36088628 — Surrogate Endpoint (SUR): Bone mineral density
Study 35681097 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34196973 — Surrogate Endpoint (SUR): Serum creatinine
Study 32836103 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32101663 — Surrogate Endpoint (SUR): Pathological complete response
Study 36166781 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34173298 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study 35957925 — Predictive Biomarker (PRD): GDNF mRNA
Genes: GDNF
Study 32861603 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32736338 — Surrogate Endpoint (SUR): Blood pressure
Study 34563585 — Surrogate Endpoint (SUR): Blood pressure
Study 34563585 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 34528981 — Predictive Biomarker (PRD): ALDH2 mRNA
Genes: ALDH2; ALDM
Study 32279172 — Monitoring Biomarker (MOI): HBV DNA
Study 35610712 — Surrogate Endpoint (SUR): Blood pressure
Study 35149568 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study 34296283 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 32711554 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 32711554 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 32221052 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 32221052 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 36199257 — Predictive Biomarker (PRD): MVD mRNA
Genes: MVD; MPD
Study 36199257 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 32229466 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32229466 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 33771716 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33771716 — Predictive Biomarker (PRD): CYP3A4 mRNA
Genes: CYP3A4; CYP3A3
Study 32975161 — Safety Biomarker (SAF): Aminopeptidase N
Genes: ANPEP; APN; CD13; PEPN
Study 35988167 — Predictive Biomarker (PRD): CNP mRNA
Genes: CNP
Study 34507350 — Predictive Biomarker (PRD): Lymphocyte activation antigen CD30
Genes: TNFRSF8; CD30; D1S166E
Study 33098434 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33098434 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 36443769 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 36443769 — Surrogate Endpoint (SUR): Blood pressure
Study 33782684 — Surrogate Endpoint (SUR): Blood pressure
Study 32043808 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 35939865 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35939865 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 35939865 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study 35939865 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34276009 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 33905962 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 35367069 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 33548518 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 36064525 — Surrogate Endpoint (SUR): Blood pressure
Study 36404525 — Pharmacodynamic Biomarker (PDY): Fibroblast growth factor receptor
Study 33565691 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 33565691 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 33565691 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 33565691 — Pharmacodynamic Biomarker (PDY): Stromal cell-derived factor 1
Genes: CXCL12; SDF1; SDF1A; SDF1B
Study 33565691 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33565691 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33565691 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36267318 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 36267318 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34037993 — Predictive Biomarker (PRD): CCL17 mRNA
Genes: CCL17; SCYA17; TARC
Study 34037993 — Safety Biomarker (SAF): IL4
Genes: BSF1; IL-4; BCGF1; BCGF-1; MGC79402
Study 34037993 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Interleukin 13
Genes: IL13; NC30
Study 34037993 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Immunoglobulin E
Study 32112136 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 32693214 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 34927230 — Predictive Biomarker (PRD): LPL mRNA
Genes: LPL; LIPD
Study 32144908 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 34649266 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34649266 — Predictive Biomarker (PRD): IL6
Genes: IL-6; BSF2; HGF; HSF
Study 34649266 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35926544 — Surrogate Endpoint (SUR): Blood pressure
Study 35169095 — Predictive Biomarker (PRD): NF2 mRNA
Genes: NF2; SCH
Study 35169095 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study 32439340 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 34260716 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34707516 — Predictive Biomarker (PRD): TRIOBP mRNA
Genes: TRIOBP; KIAA1662; TARA; HRIHFB2122
Study 35577034 — Surrogate Endpoint (SUR): Blood pressure
Study 32891803 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 32891803 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33846555 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33992249 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33992249 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32604783 — Safety Biomarker (SAF): miR-200c
Genes: MIR200C
Study 32604783 — Safety Biomarker (SAF): miR-16
Study 32604783 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-21
Genes: MIR21
Study 32604783 — Predictive Biomarker (PRD); Safety Biomarker (SAF): miR-34a
Genes: MIR34A
Study 33783227 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 32416830 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 33595213 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33595213 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Intercellular adhesion molecule 1
Genes: ICAM1
Study 32405071 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study 32405071 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 32405071 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 32405071 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 36383269 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 36383269 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36383269 — Safety Biomarker (SAF): BDNF
Study 36232176 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 36232176 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 33319467 — Surrogate Endpoint (SUR): Blood pressure
Study 32629392 — Predictive Biomarker (PRD): SH2B3 mRNA
Genes: SH2B3; LNK
Study 33321509 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 35613766 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 33939245 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 36143240 — Predictive Biomarker (PRD): Exhaled nitric oxide
Study 33782879 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33782879 — Surrogate Endpoint (SUR): Blood pressure
Study 35319298 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33973161 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 33552234 — Predictive Biomarker (PRD): ESD mRNA
Genes: ESD
Study 33004679 — Predictive Biomarker (PRD): COMP mRNA
Genes: COMP
Study 32555024 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 35990242 — Surrogate Endpoint (SUR): Blood pressure
Study 35990242 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32478400 — Predictive Biomarker (PRD): HOXA10 mRNA
Genes: HOXA10; HOX1H
Study 32478400 — Predictive Biomarker (PRD): MEIS1 mRNA
Genes: MEIS1
Study 32478400 — Predictive Biomarker (PRD): LIF mRNA
Genes: LIF; HILDA
Study 35763704 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34480632 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Angiopoietin-2
Genes: ANGPT2
Study 36241476 — Surrogate Endpoint (SUR): Serum potassium
Study 35473809 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study 35473809 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor receptor 2
Genes: KDR; FLK1; VEGFR2
Study 35473809 — Safety Biomarker (SAF): Reactive oxygen species
Study 34044875 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 32662069 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study 32085394 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 32085394 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32085394 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 35691282 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study 34628408 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 35933083 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35933083 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36280642 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33058438 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study 33176887 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 35843115 — Predictive Biomarker (PRD): NINL mRNA
Genes: NINL; KIAA0980; NLP
Study 32869813 — Predictive Biomarker (PRD): CCK mRNA
Genes: CCK
Study 32487568 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33667406 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32769877 — Predictive Biomarker (PRD): GGT1 mRNA
Genes: GGT1; GGT
Study 32769877 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 32769877 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32769877 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34808006 — Surrogate Endpoint (SUR): Probing pocket depth
Study 32161056 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 33650758 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study 35470582 — Predictive Biomarker (PRD): TBP mRNA
Genes: TBP; GTF2D1; TF2D; TFIID
Study 32770730 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 32546973 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 35294524 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34030219 — Surrogate Endpoint (SUR): Blood pressure
Study 34330457 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34970881 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34970881 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34970881 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 33123718 — Surrogate Endpoint (SUR): Serum creatinine
Study 32349746 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 33310265 — Surrogate Endpoint (SUR): Blood pressure
Study 32694382 — Surrogate Endpoint (SUR): Blood pressure
Study 35640787 — Predictive Biomarker (PRD): SLC40A1 mRNA
Genes: SLC40A1; FPN; FPN1; IREG1; SLC11A3; MSTP079
Study 35640787 — Predictive Biomarker (PRD): SYNM mRNA
Genes: SYNM; DMN; KIAA0353; SYN
Study 32605910 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 33279558 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 34794388 — Surrogate Endpoint (SUR): Blood pressure
Study 33389265 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HP mRNA
Genes: HP
Study 32586693 — Predictive Biomarker (PRD): SLC12A3 mRNA
Genes: SLC12A3; NCC; TSC
Study 32586693 — Predictive Biomarker (PRD): GAD1 mRNA
Genes: GAD1; GAD; GAD67
Study 33704378 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 33185670 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 33185670 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32826830 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study 34114771 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 34842202 — Predictive Biomarker (PRD): WARS1 mRNA
Genes: WARS1; IFI53; WARS; WRS
Study 35444577 — Predictive Biomarker (PRD): SCT mRNA
Genes: SCT
Study 33568346 — Predictive Biomarker (PRD): GEM mRNA
Genes: GEM; KIR
Study 33079133 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 33079133 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 32593918 — Predictive Biomarker (PRD): Leucine-rich alpha-2-glycoprotein
Genes: LRG1; LRG
Study 32157524 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 33180175 — Safety Biomarker (SAF): DRD3
Study 33450668 — Pharmacodynamic Biomarker (PDY): Serum phosphate
Study 33450668 — Surrogate Endpoint (SUR): Serum calcium
Study 32219502 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 35445718 — Predictive Biomarker (PRD): FGFR1 mRNA
Genes: FGFR1; BFGFR; CEK; FGFBR; FLG; FLT2; HBGFR
Study 35445718 — Predictive Biomarker (PRD): PDGFRB mRNA
Genes: PDGFRB; PDGFR; PDGFR1
Study 32168298 — Surrogate Endpoint (SUR): Serum creatinine
Study 34719411 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 32227554 — Predictive Biomarker (PRD): TRPV4 mRNA
Genes: TRPV4; VRL2; VROAC
Study 33059997 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 34077627 — Predictive Biomarker (PRD): UST mRNA
Genes: UST; DS2ST
Study 35437467 — Predictive Biomarker (PRD): SERPINA1 mRNA
Genes: SERPINA1; AAT; PI; PRO0684; PRO2209
Study 32585017 — Pharmacodynamic Biomarker (PDY): Cyclic guanosine monophosphate
Study 34017029 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34017029 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35379238 — Safety Biomarker (SAF): Cardiac troponin I
Genes: TNNI3; TNNC1
Study 32290521 — Predictive Biomarker (PRD): HSPA1B mRNA
Genes: HSPA1B; HSP72
Study 32290521 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 35659521 — Safety Biomarker (SAF): Coagulation factor IIa
Genes: F2
Study 35659521 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 35468321 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 35468321 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 33429736 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 32886401 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 32730181 — Surrogate Endpoint (SUR): Hematologic response
Study 33127944 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study 34305816 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study 35198927 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 32456525 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 32456525 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 32456525 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 36496367 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 36496367 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 32416978 — Predictive Biomarker (PRD): AMH mRNA
Genes: AMH; MIF
Study 32551097 — Surrogate Endpoint (SUR): Blood pressure
Study 33361470 — Surrogate Endpoint (SUR): Blood pressure
Study 34508257 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 34964363 — Surrogate Endpoint (SUR): Blood pressure
Study 32973117 — Predictive Biomarker (PRD): SLN mRNA
Genes: SLN
Study 34837305 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 36007724 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 32327428 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 33491027 — Surrogate Endpoint (SUR): Blood pressure
Study 32480417 — Safety Biomarker (SAF): von Willebrand factor
Genes: VWF; F8VWF
Study 35078765 — Surrogate Endpoint (SUR): Serum sodium
Study 34148781 — Predictive Biomarker (PRD): Cyclin-dependent kinase-like 5
Genes: CDKL5; STK9
Study 35622826 — Predictive Biomarker (PRD): ERAS mRNA
Genes: ERAS; HRAS2; HRASP
Study 33010470 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 35866585 — Predictive Biomarker (PRD): RPE mRNA
Genes: RPE; HUSSY-17
Study 32867994 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 32867994 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 36255569 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 32761610 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study 33245168 — Predictive Biomarker (PRD): NPY mRNA
Genes: NPY
Study 34118178 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 33247448 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1